A detailed history of Spire Wealth Management transactions in Repligen Corp stock. As of the latest transaction made, Spire Wealth Management holds 35 shares of RGEN stock, worth $5,013. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 38 7.89%
Holding current value
$5,013
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$120.0 - $182.95 $360 - $548
-3 Reduced 7.89%
35 $4,000
Q1 2024

Apr 24, 2024

SELL
$170.78 - $208.42 $683 - $833
-4 Reduced 9.52%
38 $6,000
Q4 2023

Feb 06, 2024

BUY
$114.17 - $185.35 $114 - $185
1 Added 2.44%
42 $7,000
Q3 2023

Nov 08, 2023

BUY
$138.78 - $176.51 $555 - $706
4 Added 10.81%
41 $6,000
Q2 2023

Aug 09, 2023

BUY
$138.42 - $180.31 $1,661 - $2,163
12 Added 48.0%
37 $5,000
Q4 2022

Feb 03, 2023

BUY
$162.42 - $220.56 $487 - $661
3 Added 13.64%
25 $4,000
Q1 2021

May 21, 2021

BUY
$180.37 - $226.26 $3,968 - $4,977
22 New
22 $4,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.95B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.